First, we demonstrate that the expression of RAR-β is downregulated in PDAC tissues, a loss that correlates with tumour stage and is concomitant with an increase in myosin light chain 2 (MLC-2) expression, but can be restored via RAR-β activation. This evidence concerns the gene MYL9 and neoplasm.